Clinical trial

A Study of 1592U89 in HIV-Infected Patients

NCT00002388

StatusCOMPLETED

Study typeINTERVENTIONAL

Start dateUnknown

PhasePHASE1

Study timeline

Registry last updated2005-06-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV Infectionsunresolved

Interventions

Abacavir sulfateDRUG · verified · RxNorm: abacavir sulfate

Sponsors & collaborators

Glaxo Wellcomelead sponsor

Mapped research locations

BostonMassachusetts, United States1 AlbanyNew York, United States1 EvanstonIllinois, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00002388 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.